Evasion of pathogens by avoiding recognition or eradication by complement, in part via molecular mimicry

Molecular Immunology

Volumn 36, Issue 4-5, 1999, Pages 249-260

  Würzner, Reinhard ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Escape; Immune defence; Resistance

Indexed keywords

COMPLEMENT;

ANTIGEN RECOGNITION; BLOOD; COMPLEMENT ACTIVATION; COMPLEMENT DEPENDENT CYTOTOXICITY; COMPLEMENT INHIBITION; CONFERENCE PAPER; IMMUNE SYSTEM; IMMUNITY; MOLECULAR MIMICRY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BLOOD-BORNE PATHOGENS; COMPLEMENT SYSTEM PROTEINS; HUMANS; INFECTION; MOLECULAR MIMICRY;

EID: 0345712321     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(99)00049-8     Document Type: Conference Paper

References (101)

1. Akesson P., Sjoholm A.G., Bjorck L. Protein SIC, a novel extracellular protein of Streptococcus pyogenes interferin with complement function. J. Biol. Chem. 271:1996;1081-1088.
2. Albrecht J.C., Fleckenstein B. New member of the multigene family of complement control proteins in herpes virus saimiri. J. Virol. 66:1992;3937-3940.
3. Albrecht J.C., Nicholas J., Camerun K.R., Newman C., Fleckenstein B., Honess R.W. Herpes virus saimiri has a gene specifying a homologue of the cellular membrane glycoprotein CD59. Virology. 190:1992;527-530.
4. Andrews N.W., Abrams C.K., Slatin S.L., Griffiths G. A T. cruzi-secreted protein immunologically related to the complement component C9: evidence for membrane pore-forming activity at low pH. Cell. 61:1990;1277-1287.
5. Berge A., Kihlberg B.M., Sjoholm A.G., Bjorck L. Streptococcal protein H forms soluble complement-activating complexes with IgG, but inhibits complement activation by IgG-coated targets. J. Biol. Chem. 272:1997;20774-20781.
6. Bergelson J.M., Chan M., Solomon K.R., Stjohn N.F., Lin H.M., Finberg R.W. Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses. Proc. Natl. Acad. Sci. USA. 91:1994;6245-6248.
7. Berggard K., Johnsson E., Mooi F.R., Lindahl G. Bordetella pertussis binds the human complement regulator C4BP: role of filamentous hemagglutinin. Infect. Immun. 65:1997;3638-3643.
8. Bhakdi S., Traunum Jensen J. Damage to cell membranes by pore-forming bacterial cytolysins. Prog. Allergy. 40:1988;1-43.
9. Braga L.L., Ninomiya H., McCoy J.J., Eacker S., Wiedmer T., Pham C., Wood S., Sims P.J., Petri W.A. Jr. Inhibition of the complement membrane attack complex by the galactose-specific adhesin of Entamoeba histolytica. J. Clin. Invest. 90:1992;1131-1137.
10. Breitner-Ruddock S., Würzner R., Schulze J., Brade V. Heterogeneity within the genospecies of Borrelia burgdorferi in regard of the complement dependent bacteriolysis. Med. Microbiol. Immunol. 185:1997;253-260.
11. Bullock W.E., Wright D.S. Role of the adherence-promoting receptors, CR3, LFA-1 and p150,95, in binding of histoplasma capsulatum by human macrophages. J. Exp. Med. 165:1987;195-210.
12. Calderone R.A., Linehan L., Wadsworth E., Sandberg A.L. Identification of C3 d receptors on candida albicans. Infect. Immun. 56:1988;252-258.
13. Chaudhuri G., Chang K.P. Acid protease activity of a major surface membrane glycoprotein (gp63) from leishmania mexicana promastigotes. Mol. Biochem. Parasitol. 27:1988;43-52.
14. China B., Sory M.P., N'Guyen B.T., De-Bruyere M., Cornelis G.R. Role of the YadA protein in prevention of opsonization of Yersinia enterocolitica by C3b molecules. Infect. Immun. 61:1993;3129-3136.
15. Cooper N.R. Complement evasion strategies of microorganisms. Immunol. Today. 12:1991;327-331.
16. Cywes C., Godenir N.L., Hoppe H.C., Scholle R.R., Steyn L.M., Kirsch R.E., Ehlers M.R.W. Nonopsonic binding of Mycobacterium tuberculosis to human complement receptor type 3 expressed in Chinese hamster ovary cells. Infect. Immun. 64:1996;5373-5383.
17. Da Silva R.P., Hall B.F., Joiner K.A., Sacks D.L. CR1, the C3b receptor, mediates binding of infective leishmania major metacyclic poromastigotes to human macrophages. J. Immunol. 143:1989;617-622.
18. Diaz A., Ferreira A., Sim R.B. Complement evasion by echinococcus granulosus. Sequestration of host factor H in the hydatid cyst wall. J. Immunol. 158:1997;3779-3786.
19. Dorig R.E., Marcil A., Chopra A., Richardson C.D. The human CD46 molecule is a receptor for measles virus (Edmonston Strain). Cell. 75:1993;295-305.
20. Duffus W.P.H., Franks D. In vitro effect of immune serum and bovine granulocytes on juvenile Fasciola hepatica. Clin. Exp. Immunol. 41:1980;430-440.
21. Ferrante A., Allison A.C. Alternative pathway activation of complement by african trypanosomes lacking a glycoprotein coat. Parasite Immunol. 5:1983;491-498.
22. Fischer E., Ouaissi M.A., Velge P., Cornette J., Kazatchkine M.D. gp58/68, a parasite component that contributes to the escape of the trypomastigote form of T. cruzi from damage by the human alternative complement pathway. Immunology. 65:1988;299-303.
23. Fishelson Z. Complement evasion by parasites: search for Achilles heel. Clin. Exp. Immunol. 86:(Suppl.1):1991;47-52.
24. Fishelson Z. Complement-related proteins in pathogenic organisms. Springer Semin. Immunopathol. 15:1994;345-368.
25. Frevert U., Reinwald E. Trypanosoma congolense bloodstream forms evade complement lysis in vitro by shedding of immune complexes. Eur. J. Cell. Biol. 52:1990;264-269.
26. Friedman H.M., Cohen G.H., Eisenberg R.J., Seidel C.A., Cines D.B. Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells. Nature. 309:1984;633-635.
27. Gale C., Finkel D., Tao N., Meinke M., McClellan M., Olson J., Kendrick K., Hostetter M. Cloning and expression of a gene encoding an integrin-like protein in Candida albicans. Proc. Natl. Acad. Sci. USA. 93:1996;361-367.
28. Goundis D., Reid K.B.M. Properdin, the terminal complement components, thrombospondin and the circumsporozoite protein of malaria parasites contain similar sequence motifs. Nature. 335:1988;82-85.
29. Grenier D. Inactivation of human serum bactericidal activity by a trypsin-like protease isolated from porphyromonas gingivalis. Infect. Immun. 60:1992;1854-1857.
30. Gruber A., Lukasser-Vogl E., von Zepelin Borg M., Dierich M.P., Würzner R. Human immunodeficiency virus type 1 gp160/gp41 binding to Candida albicans selectively enhances candidal virulence in vitro. J. Infect. Disorders. 177:1998;1057-1063.
31. Hall B.R., Joiner K.A. Strategies of obligate intracellular parasites for evading host defences. Immunol. Today. 12:1991;A22-A27.
32. Heffernan E.J., Reed S., Hackett J., Fierer J., Roudier C., Guiney D. Mechanism of resistence to complement-mediated killing of bacteria encoded by the Salmonella typhimurium virulence plasmid gene rck. J. Clin. Invest. 90:1992;953-964.
33. Heidenreich F., Dierich M.P. Candida albicans and Candida stellatoidea, in contrast to other Candida species, bind iC3b and C3 d but not C3b. Infect. Immun. 50:1985;598-600.
34. Hermoso T., Fishelson Z., Becker S.I., Hirschberg K., Jaffe C.L. Leishmanial protein kinases phosphorylate components of the complement system. EMBO J. 10:1991;4061-4067.
35. Hong Y., Kim C.W., Ghebrehiwet B. Trichinella spiralis: activation of complement by infective larvae, adults, and newborn larvae. Exp. Parasitol. 74:1992;290-299.
36. Hong Y.Q., Ghebrehiwet B. Effect of pseudomonas aeruginosa elastase and alkaline protease on serum complement and isolated components C1q and C3. Clin. Immunol. Immunopathol. 62:1992;133-138.
37. Horstmann R.D., Sievertsen H.J., Knobloch J., Fischetti V.A. Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H. Proc. Natl. Acad. Sci. USA. 85:1988;1657-1661.
38. Iida K., Whitlow M.B., Nussenzweig V. Amastigotes of Trypanosoma cruzi escape destruction by the terminal complement components. J. Exp. Med. 169:1989;881-891.
39. Johnsson E., Berggard K., Kotarsky H., Hellwage J., Zipfel P.F., Sjobring U., Lindahl G. Role of the hypervariable region in streptococcal M proteins: binding of a human complement inhibitor. J. Immunol. 161:1998;4894-4901.
40. Joiner K.A., Hammer C.H., Brown E.J., Cole R.J., Frank M.M. Studies on the mechanism of bacterial resistance to complement-mediated killing. J. Exp. Med. 155:1982;797-808.
41. Joiner K.A. Complement evasion by bacteria and parasites. A. Rev. Microbiol. 42:1988;201-230.
42. Joiner K.A., da Silva Dias W., Rimoldi M.T., Hammer C.H., Sher A., Kipnis T.L. Biochemical characterization of a factor produced by trypomastigotes of Trypanosoma cruzi that accelerates the decay of complement C3 convertases. J. Biol. Chem. 263:1988;11327-11335.
43. Jokiranta T.S., Jokipii L., Meri S. Complement resistance of parasites. Scand. J. Immunol. 42:1995;5-20.
44. Kallstrom H., Liszewski M.K., Atkinson J.P., Jonsson A.B. Membrane cofactor protein (MCP or CD46) is a cellular pilus receptor for pathogenic Neisseria. Mol. Microbiol. 25:1997;639-647.
45. Kawamoto Y., Kojima K., Hitsumoto Y., Okada H., Holers V.M., Miyama A. The serum resistance of malaria-infected erythrocytes. Immunology. 91:1997;7-12.
46. Kipnis T.L., David J.R., Alper C.A., Sher A., da Silva Dias W. Enzymatic treatment transforms trypomastigotes of Trypanosoma cruzi into activators of alternative complement pathway and potentiates their uptake by macrophages. Proc. Natl. Acad. Sci. USA. 78:1981;602-605.
47. Kotwal G.J. The great escape: immune evasion by pathogens. Immunologist. 4:1996;157-164.
48. Kotwal G.J., Isaacs S.N., McKenzie R., Frank M.M., Moss B. Inhibition of the complement cascade by the major secretory protein of vaccinia virus. Science. 250:1990;827-830.
49. Laclette J.P., Shoemaker C.B., Richter D., Arcos L., Pante N., Cohen C., Bing D., Nicholson-Weller A. Paramyosin inhibits complement C1. J. Immunol. 148:1992;124-128.
50. Liang-Takasaki C., Saxén H., Mäkelä P.H., Leive L. Complement activation by polysaccharide of lipopolysaccharide: an important virulence determinant of salmonellae. Infect. Immun. 41:1983;563-569.
51. Malhotra R., Willis A.C., Jensenius J.C., Jackson J., Sim R.E. Structure and homology of human C1q receptor (collectin receptor). Immunology. 78:1993;341-348.
52. Marikovsky M., Parizade M., Arnon R., Fishelson Z. Complement regulation on the surface of cultured schistosomula and adult worms of Schistosoma mansoni. Eur. J. Immunol. 20:1990;221-227.
53. Marschang P., Sodroski J., Würzner R., Dierich M.P. Decay-accelerating factor (CD55) protects human immunodeficiency virus type 1 from inactivation by human complement. Eur. J. Immunol. 25:1995;285-290.
54. McLaren D.J., Hockley D.J. Blood flukes have a double membrane. Nature. 269:1977;147-149.
55. McLaren D.J. Disguise as an evasive strategem of parasitic organisms. Parasitology. 88:1984;597-611.
56. Merino S., Camprubi S., Alberti S., Benedi V-J., Tomas J.M. Mechanisms of Klebsiella pneumoniae resistance to complement-mediated killing. Infect. Immun. 60:1992;2529-2535.
57. Mold C., Bradt B.M., Nemerow G.R., Cooper N.R. Epstein-Barr virus regulates activation and processing of the third component of complement. J. Exp. Med. 168:1988;949-969.
58. Neipel F., Albrecht J.C., Fleckenstein B. Cell-homologous genes in the kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenicity? J. Virology. 71:1997;4187-4192.
59. Nemerow G.R., Mold C., Schwend V.K., Tollefson V., Cooper N.R. Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr Virus (EBV) to the EBV/C3 d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3 d. J. Virol. 61:1987;1416-1420.
60. Norris K.A., Bradt B.M., Cooper N.R., So M. Characterization of a Trypanosoma cruzi C3 binding protein with functional and genetic similarities to the human complement regulatory protein decay accelerating factor. J. Immunol. 147:1991;2240-2247.
61. Norris K.A. Ligand-binding renders the 160 kDa Trypanosoma cruzi complement regulatory protein susceptible to proteolytic cleavage. Microb. Pathog. 21:1996;235-248.
62. Nunes A.C., Almeidacampos F.R., Horta M.F., Ramalhopinto F.J. Leishmania amazonensis promastigotes evade complement killing by interfering with the late steps of the cascade. Parasitology. 115:1997;601-609.
63. Oda T., Kojima Y., Akaike T., Ijiri S., Molla A., Maeda H. Inactivation of chemotactic activity of C5a by the serratial 56-kilodalton protease. Infect. Immun. 58:1990;1269-1272.
64. Okada N., Liszewski M.K., Atkinson J.P., Caparon M. Membrane cofactor protein (CD46) is a keratinocyte receptor for the M protein of the group A streptococcus. Proc. Natl. Acad. Sci. USA. 92:1995;2489-2493.
65. Parizade M., Arnon R., Lachmann P.J., Fishelson Z. Functional and antigenic similaries between a 94-kD protein of schistosoma mansoni (SCIP-1) and human CD59. J. Exp. Med. 179:1994;1625-1636.
66. Pearce E.J., Hall B.F., Sher A. Host-specific evasion of the alternative complement pathway by schistosomes correlates with the presence of a phospholipase C-sensitive surface molecule resembling human decay accelerating factor. J. Immunol. 144:1990;2751-2756.
67. Pham T.Q., Goluszko P., Popov V., Nowicki S., Nowicki B.J. Molecular cloning and characterization of Dr-II, a nonfimbrial adhesin-I-like adhesin isolated from gestational pyelonephritis-associated Escherichia coli that binds to decay-accelerating factor. Infect. Immun. 65:1997;4309-4318.
68. Pramoonjago P., Kaneko M., Kinoshita T., Ohtsubo E., Takeda J., Hong K., Inagi R., Inoue K. Role of TraT protein, an anticomplementary protein produced in Escherichia coli by R100 factor, in serum resistance. J. Immunol. 148:1992;827-836.
69. Puentes S.M., Sacks D.L., da Silva R., Joiner K.A. Complement binding by two developmental stages of Leishmania major promastigotes varying in expression of a surface lipophosphoglycan. J. Exp. Med. 167:1988;887-902.
70. Puentes S.M., Dwyer D.M., Bates P.A., Joiner K.A. Binding and release of C3 from Leishmania donovani promastigotes during incubation in normal human serum. J. Immunol. 143:1989;3743-3749.
71. Puentes S.M., Da-Silva R.P., Sacks D.L., Hammer C.H., Joiner K.A. Serum resistance of metacyclic stage Leishmania major promastigotes is due to release of C5b-9. J. Immunol. 145:1990;4311-4316.
72. Ram S., Sharma A.K., Simpson S.D., Gulati S., Mcquillen D.P., Pangburn M.K., Rice P.A. A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae. J. Exp. Med. 187:1998;743-752.
73. Ram S., Mcquillen D.P., Gulati S., Elkins C., Pangburn M.K., Rice P.A. Binding of complement factor H to loop 5 of porin protein 1A: a molecular mechanism of serum resistance of nonsialylated Neisseria gonorrhoeae. J. Exp. Med. 188:1998;671-680.
74. Rautemaa R., Jarvis G.A., Marnila P., Meri S. Acquired resistance of Escherichia coli to complement lysis by binding of glycophosphoinositol-anchored protectin (CD59). Infect. Immun. 66:1998;1928-1933.
75. Reed S.L., Keene W.E., McKerrow J.H., Gigli I. Cleavage of C3 by a neutral cysteine proteinase of entamoeba histolytica. J. Immunol. 143:1989;189-195.
76. Reed S.L., Ember J.A., Herdman D.S., DiScipio R.G., Hugli T.E., Gigli I. The extracellular neutral cysteine proteinase of Entamoeba histolytica degrades anaphylatoxins C3a and C5a. J. Immunol. 155:1995;266-274.
77. Rimoldi M.T., Tenner A.J., Bobak D.A., Joiner K.A. Complement component C1q enhances invasion of human mononuclear phagocytes and fibroblasts by Trypanosoma cruzi trypomastigotes. J. Clin. Invest. 84:1989;1982-1989.
78. Rogers R.A., Jack R.M., Furlong S.T. Lipid and membrane protein transfer from human neutrophils to schistosomes is mediated by ligand binding. J. Cell. Sci. 106:1993;485-491.
79. Rokita E., Makristathis A., Presterl E., Rotter M.L., Hirschl A.M. Helicobacter pylori urease significantly reduces opsonization by human complement. J. Infect. Disorders. 178:1998;1521-1525.
80. Russell D.G., Talamas-Rohana P. Leishmania and the macrophage: a marriage of inconvenience. Immunol. Today. 10:1989;328-333.
81. Schenkein H.A., Fletcher H.M., Bodnar M., Macrina F.L. Increased opsonization of a prtH-defective mutant of Porphyromonas gingivalis W83 is caused by reduced degradation of complement-derived opsonins. J. Immunol. 154:1995;5331-5337.
82. Schlesinger L.S., Bellinger-Kawahara C.G., Payne N.R., Horwitz M.A. Phagocytosis of mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. J. Immunol. 144:1990;2771-2780.
83. Schwimmbeck P.L., Yu D.T., Oldstone M.B. Autoantibodies to HLA B27 in the sera of HLA B27 patients with ankylosing spondylitis and Reiter's syndrome. Molecular mimicry with Klebsiella pneumoniae as potential mechanism of autoimmune disease. J. Exp. Med. 166:1987;173-181.
84. Silva E.E., Clarke M.W., Podesta R.B. Characterization of a C3 receptor on the envelope of Schistosoma mansoni. J. Immunol. 151:1993;7057-7066.
85. Sölder B.M., Reisinger E.C., Köfler D., Bitterlich G., Lehr H.A., Wachter H., Dierich M.P. Complement receptors: another port of entry for HIV. Lancet. ii:1989;271-272.
86. Spiller O.B., Morgan B.P., Tufaro F., Devine D.V. Altered expression of host-encoded complement regulators on human cytomegalovirus-infected cells. Eur. J. Immunol. 26:1996;1532-1538.
87. Stemmer F., Loos M. Evidence for direct binding of the first component of complement, C1, to outer membrane proteins from Salmonella minnesota. Curr. Top. Microbiol. Immunol. 121:1985;73-84.
88. Stoiber H., Ebenbichler C., Schneider R., Janatova J., Dierich M.P. Interaction of several complement proteins with gp120 and gp41, the two envelope glycoproteins of HIV-1. AIDS. 9:1995;19-26.
89. Stoiber H., Schneider R., Janatova J., Dierich M.P. Human complement proteins C3b, C4b, factor H and properdin react with specific sites in gp120 and gp41, the envelope proteins of HIV-1. Immunobiology. 193:1995;98-113.
90. Stoiber H., Pinter C., Siccardi A.G., Clivio A., Dierich M.P. Efficient destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF, CD55). J. Exp. Med. 183:1996;307-310.
91. Stoiber H., Frank I., Spruth M., Schwendinger M., Mullauer B., Windisch J.M., Schneider R., Katinger H., Ando I., Dierich M.P. Inhibition of HIV-1 infection in vitro by monoclonal antibodies to the complement receptor type 3 (CR3): an accessory role for CR3 during virus entry? Mol. Immunol. 34:1997;855-863.
92. Thern A., Stenberg L., Dahlback B., Lindahl G. Ig-binding surface proteins of Streptococcus pyogenes also bind human C4b-binding protein (C4BP), a regulatory component of the complement system. J. Immunol. 54:1995;375-386.
93. Toney D.M., Marciano-Cabral F. Membrane vesiculation of naegleria fowleri amoebae as a mechnism for resisting complement damage. J. Immunol. 152:1994;2952-2959.
94. Tremblay M., Meloche S., Sekaly R.P., Wainberg M.A. Complement receptor 2 mediates enhancement of human immunodeficiency virus 1 infection in Epstein-Barr virus-carrying B cells. J. Exp. Med. 171:1990;1791-1796.
95. Van Dam G.J., Seino J., Rotmans J.P., Daha M.R., Deelder A.M. Schistosoma mansoni circulating anodic antigen but not circulating cathodic antigen interacts with complement component C1q. Eur. J. Immunol. 23:1993;2807-2812.
96. Van den Berg R.H., Faber-Krol M.C., van de Klundert J.A., van Es L.A., Daha M.R. Inhibition of the hemolytic activity of the first component of complement C1 by an escherichia coli C1q binding protein. J. Immunol. 156:1996;4466-4473.
97. Van der Plasschen A., Mathew E., Hollinshead M., Sim R.B., Smith G.L. Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope. Proc. Natl. Acad. Sci. USA. 95:1998;7544-7549.
98. Wolf U., Bauer D., Traub W. Metalloproteases of serratia liquefaciens: degradation of purified human serum proteins. Int. J. Med. Microbiol. 276:1991;16-26.
99. Würzner R., Gruber A., Stoiber H., Spruth M., Chen Y.H., Lukasser-Vogl E., Schwendinger M., Dierich M.P. Human immunodeficiency virus type 1 gp41 binds to Candida albicans via complement C3-like regions. J. Infect. Disorders. 176:1997;492-498.
100. Yamakami K., Hamajima F., Akao S., Tadakuma T. Purification and characterization of acid cysteine protease from metacercariae of the mammalian trematode parasite Paragonimus westermani. Eur. J. Biochem. 233:1995;490-497.
101. Zhao Z-S., Granucci F., Yeh L., Schaffer P.A., Cantor H. Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. Science. 279:1998;1344-1347.